FDA OKs Another Monoclonal Antibody to Protect Against RSV in Infants

(MedPage Today) — The FDA approved clesrovimab (Enflonsia) to prevent lower respiratory tract disease from respiratory syncytial virus (RSV) in infants born during or entering their first RSV season, drugmaker Merck announced on Monday.
The long…

Source link : https://www.medpagetoday.com/pediatrics/rsv/115985

Author :

Publish date : 2025-06-09 21:31:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

FDA OKs Another Monoclonal Antibody to Protect Against RSV in Infants

Cycling in Midlife Tied to Lower Risk of Dementia

RFK Jr. Ousts All of CDC’s Vaccine Advisors

Related Posts

Can 3 Questions Flag Depression? PHQ-3 Tested

Trump Admin Is Launching a New Private Health Tracking System With Big Tech’s Help

APA Opposes RFK Jr. Plan; Murder-Suicide Rates; D.I.Y. Fecal Transplant for Bipolar

Let a breakthrough in measuring body clocks ease the ills of shiftwork

COVID Infection May Ignite Dormant Cancer in Survivors, Study Says

This Severe Flu-Related Neurologic Complication Occurred Mostly in Healthy Kids

Can 3 Questions Flag Depression? PHQ-3 Tested

Trump Admin Is Launching a New Private Health Tracking System With Big Tech’s Help

APA Opposes RFK Jr. Plan; Murder-Suicide Rates; D.I.Y. Fecal Transplant for Bipolar

Let a breakthrough in measuring body clocks ease the ills of shiftwork

COVID Infection May Ignite Dormant Cancer in Survivors, Study Says

This Severe Flu-Related Neurologic Complication Occurred Mostly in Healthy Kids

The Right to Discriminate Against a Patient

Rise in STEC Infections Linked to Food and Overseas Travel

Categories

Archives